Key result
CRT improves exercise tolerance, RVEF, and renal function in a failing systemic RV case.
Why the study?
The role of cardiac resynchronization therapy in managing adult congenital heart disease patients with a failing right (systemic) ventricle is unknown.
Does CRT improve clinical and echocardiographic outcomes in an adult patient with transposition of the great arteries and a failing systemic right ventricle?
Comparison
CRT using a hybrid transvenous/epicardial approach
Design
Case report
Authors
Loading...
CRT may benefit select adults with failing systemic RV; hypothesis-generating and requires prospective validation.
Case Report (n=1)
Does CRT improve clinical and echocardiographic outcomes in an adult patient with transposition of the great arteries and a failing systemic right ventricle?
CRT may be a viable therapeutic option for adult congenital heart disease patients with a failing systemic right ventricle.
Cowburn et al. (2005) conducted a case report in Adult congenital heart disease with a failing right (systemic) ventricle (n=1). Cardiac resynchronization therapy (CRT) was evaluated on Clinical and echocardiographic improvement (exercise tolerance, right ventricular ejection fraction, diuretic requirements, renal function). Cardiac resynchronization therapy improved exercise tolerance, right ventricular ejection fraction, and renal function in an adult patient with a failing right systemic ventricle.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: